Halozyme appoints Cortney Caudill as COO; base salary $600K, equity award $500K

HALOZYME THERAPEUTICS, INC.

Cortney Caudill appointed SVP, COO effective Oct 1, 2025; previously SVP, Chief Operations Officer since Oct 2023.
Annual base salary set at $600,000; eligible for executive incentive plans with 2025 bonus target of 50% of salary.
Receives $500K equity award (50% stock options, 50% RSUs) vesting over four years.
No family relationships or material interests in any transactions with the Company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.